Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteosarcoma

N Fuchs1, K Winkler

  • 1Department of Pediatric Hematology and Oncology, Children's University Hospital, Hamburg, Germany.

Current Opinion in Oncology
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Genetic mutations in suppressor genes are key to osteosarcoma. Research confirms MRI effectiveness, highlights methotrexate

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast assessment using next generation handheld ultrasound device based on silicon chips: a pilot study in senology.

Archives of gynecology and obstetrics·2026
Same author

From data to insights: Upscaling riverine GHG fluxes in Germany with machine learning.

The Science of the total environment·2024
Same author

Long-term results after semiconstrained distal radioulnar joint arthroplasty: A focus on complications.

Hand surgery & rehabilitation·2020
Same author

Controlled Ordering of Topological Charges in an Exciton-Polariton Chain.

Physical review letters·2018
Same author

Exciton-polariton topological insulator.

Nature·2018
Same author

Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P.) apheresis: The Freiburg preeclampsia H.E.L.P.-Apheresis study.

Pregnancy hypertension·2018
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Molecular Genetics
  • Medical Imaging

Background:

  • Osteosarcoma pathogenesis involves suppressor gene mutations, notably RB and p53.
  • Alterations in genes on chromosomes 18q and 3q may also contribute.
  • Tumor growth regulation pathways present novel therapeutic targets.

Purpose of the Study:

  • To review current findings on osteosarcoma genetics, imaging, and treatment efficacy.
  • To evaluate novel therapeutic strategies targeting tumor growth regulation.
  • To assess the impact of risk factors and treatment intensity on prognosis.

Main Methods:

  • Molecular genetic and cytogenetic investigations.
  • Magnetic resonance imaging (MRI) and dynamic gadolinium-enhanced imaging.

Related Experiment Videos

  • Review of clinical trial data for chemotherapy and immunotherapy.
  • Preclinical studies involving hypophysectomy in mice.

    • Main Results:

    • RB and p53 mutations are frequently implicated in osteosarcoma.
    • High-resolution MRI and dynamic contrast-enhanced MRI are effective for imaging and response assessment.
    • High-dose methotrexate shows 19% efficacy; immunotherapy results are inconclusive.
    • Intervention in growth factor pathways (e.g., IGF) shows promise in preclinical models.
    • Tumor response, surgical margins, and local control are critical for prognosis.
    • Known risk factors are confirmed; dose intensity did not impact prognosis.

    Conclusions:

    • Genetic mutations, particularly in suppressor genes, are central to osteosarcoma development.
    • Advanced imaging techniques are vital for diagnosis and treatment monitoring.
    • Targeting tumor growth regulation pathways offers a promising therapeutic avenue.
    • Effective local control and management of risk factors are crucial for patient outcomes.